FOS and lymphoma: These results agree with our DNA-binding studies (Fig. 1), and further support the notion that IRF4-C99R fundamentally alters IRF4 genome-wide DNA-binding patterns in lymphoma cells and enforces cooperative binding with AP-1/JUN TFs at distinct neo-AICEs.